Digitala Vetenskapliga Arkivet

Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Glycan-encoded biomimetic design for precision therapeutics
School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
KTH, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Chemistry, Glycoscience. School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.ORCID iD: 0000-0002-0968-5793
2026 (English)In: Current opinion in chemical biology, ISSN 1367-5931, E-ISSN 1879-0402, Vol. 94, article id 102739Article in journal (Refereed) Published
Abstract [en]

Carbohydrates play essential roles in biological systems, where structural diversity and glycan-mediated interactions govern molecular recognition, immune responses, and tissue organization. These features provide a foundation for nature-inspired therapeutic design. In this review, we highlight how carbohydrate-based systems translate biological principles into functional therapeutic strategies. We focus on glycan-mediated immune activation, carbohydrate-based delivery systems, and polysaccharide biomaterials. Multivalent glycan architectures can directly activate innate immune pathways and remodel the tumor microenvironment, while plant-derived polysaccharides enable biologically responsive delivery through receptor recognition and microbiota-triggered release. At the materials level, polysaccharide-based hydrogels mimic extracellular matrices and support tissue regeneration. Together, these examples illustrate how carbohydrate-based design principles can be leveraged to develop next-generation precision therapeutics that integrate effectively with biological systems.

Place, publisher, year, edition, pages
Elsevier BV , 2026. Vol. 94, article id 102739
National Category
Biochemistry Medical Biotechnology (Focus on Cell Biology, (incl. Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
URN: urn:nbn:se:kth:diva-387108DOI: 10.1016/j.cbpa.2026.102739PubMedID: 42551198Scopus ID: 2-s2.0-105046284543OAI: oai:DiVA.org:kth-387108DiVA, id: diva2:2091849
Funder
KTH Royal Institute of Technology
Note

QC 20260813

Available from: 2026-08-13 Created: 2026-08-13 Last updated: 2026-08-14Bibliographically approved

Open Access in DiVA

fulltext(4045 kB)15 downloads
File information
File name FULLTEXT01.pdfFile size 4045 kBChecksum SHA-512
adec299794b907a650c61ccfd92167438e6f9cb17804f759e755c8cf25c9b963e5fe8dd706f5e98ec9e31739aae0c13a444559fe5d64767a2c86e183799f354a
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Hsieh, Yves S. Y.
By organisation
Glycoscience
In the same journal
Current opinion in chemical biology
BiochemistryMedical Biotechnology (Focus on Cell Biology, (incl. Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 453 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf